110 related articles for article (PubMed ID: 13872969)
1. The hemolytic effect of primaquine. XV. Role of methemoglobin.
BREWER GJ; TARLOV AR; KELLERMEYER RW; ALVING AS
J Lab Clin Med; 1962 Jun; 59():905-17. PubMed ID: 13872969
[No Abstract] [Full Text] [Related]
2. The methemoglobin reduction test for primaquine-type sensitivity of erythrocytes. A simplified procedure for detecting a specific hypersusceptibility to drug hemolysis.
BREWER GJ; TARLOV AR; ALVING AS
JAMA; 1962 May; 180():386-8. PubMed ID: 13872968
[No Abstract] [Full Text] [Related]
3. The hemolytic effect of primaquine. XIII. Gradient susceptibility to hemolysis of primaquine-sensitive erythrocytes.
KELLERMEYER RW; TARLOV AR; SCHRIER SL; CARSON PE; ALVING AS
J Lab Clin Med; 1961 Aug; 58():225-33. PubMed ID: 13752331
[No Abstract] [Full Text] [Related]
4. The hemolytic effect of primaquine. XI. Decreased catalase activity in primaquine-sensitive erythrocytes.
TARLOV AR; KELLERMEYER RW
J Lab Clin Med; 1961 Aug; 58():204-16. PubMed ID: 13775336
[No Abstract] [Full Text] [Related]
5. The hemolytic effect of primaquine. III. A study of primaquine-sensitive erythrocytes.
BEUTLER E; DERN RJ; ALVING AS
J Lab Clin Med; 1954 Aug; 44(2):177-84. PubMed ID: 13184225
[No Abstract] [Full Text] [Related]
6. The hemolytic effect of primaquine. II. The natural course of the hemolytic anemia and the mechanism of its self-limited character.
DERN RJ; BEUTLER E; ALVING AS
J Lab Clin Med; 1954 Aug; 44(2):171-6. PubMed ID: 13184224
[No Abstract] [Full Text] [Related]
7. The hemolytic effect of primaquine. X. Aldolase and glyceraldehyde-3-phosphate dehydrogenase activity in primaquine-sensitive erythrocytes.
SCHRIER SL; KELLERMEYER RW; CARSON PE; ICKES CE; ALVING AS
J Lab Clin Med; 1959 Aug; 54():232-40. PubMed ID: 14443591
[No Abstract] [Full Text] [Related]
8. Methaemoglobin reduction test: a new, simple, in vitro test for identifying primaquine-sensitivity.
BREWER GJ; TARLOV AR; ALVING AS
Bull World Health Organ; 1960; 22(6):633-40. PubMed ID: 13804322
[TBL] [Abstract][Full Text] [Related]
9. OXIDATIVE HEMOLYSIS AND ERYTHROCYTE METABOLISM IN HEREDITARY ACATALASIA.
JACOB HS; INGBAR SH; JANDL JH
J Clin Invest; 1965 Jul; 44(7):1187-99. PubMed ID: 14328395
[No Abstract] [Full Text] [Related]
10. The hemolytic effect of primaquine and related compounds: a review.
BEUTLER E
Blood; 1959 Feb; 14(2):103-39. PubMed ID: 13618370
[No Abstract] [Full Text] [Related]
11. Hemolytic effect of therapeutic drugs. Clinical considerations of the primaquine-type hemolysis.
KELLERMEYER RW; TARLOV AR; BREWER GJ; CARSON PE; ALVING AS
JAMA; 1962 May; 180():388-94. PubMed ID: 14454972
[No Abstract] [Full Text] [Related]
12. The hemolytic effect of primaquine. I. The localization of the drug-induced hemolytic defect in primaquine-sensitive individuals.
DERN RJ; WEINSTEIN IM; LEROY GV; TALMAGE DW; ALVING AS
J Lab Clin Med; 1954 Feb; 43(2):303-9. PubMed ID: 13130947
[No Abstract] [Full Text] [Related]
13. The hemolytic effect of primaquine. IV. The relationship of cell age to hemolysis.
BEUTLER E; DERN RJ; ALVING AS
J Lab Clin Med; 1954 Sep; 44(3):439-42. PubMed ID: 13201853
[No Abstract] [Full Text] [Related]
14. The hemolytic effect of primaquine. IX. Enzymatic abnormalities in primaquine-sensitive erythrocytes.
SCHRIER SL; KELLERMEYER RW; CARSON PE; ICKES CE; ALVING AS
J Lab Clin Med; 1958 Jul; 52(1):109-17. PubMed ID: 13549855
[No Abstract] [Full Text] [Related]
15. The hemolytic effect of primaquine. VI. An in vitro test for sensitivity of erythrocytes to primaquine.
BEUTLER E; DERN RJ; ALVING AS
J Lab Clin Med; 1955 Jan; 45(1):40-50. PubMed ID: 13233626
[No Abstract] [Full Text] [Related]
16. The hemolytic effect of primaquine. V. Primaquine sensitivity as a manifestation of a multiple drug sensitivity.
DERN RJ; BEUTLER E; ALVING AS
J Lab Clin Med; 1955 Jan; 45(1):30-9. PubMed ID: 13233625
[No Abstract] [Full Text] [Related]
17. The hemolytic effect of primaquine. VII. Biochemical studies of drug-sensitive erythrocytes.
BEUTLER E; DERN RJ; FLANAGAN CL; ALVING AS
J Lab Clin Med; 1955 Feb; 45(2):286-95. PubMed ID: 13233657
[No Abstract] [Full Text] [Related]
18. THE MECHANISM OF HAEMOLYSIS IN FAVISM. SOME ANALOGY IN THE ACTIVITY OF PRIMAQUINE AND FAVA JUICE.
PANIZON F; ZACCHELLO F
Acta Haematol; 1965 Mar; 33():129-38. PubMed ID: 14326932
[No Abstract] [Full Text] [Related]
19. Methemoglobin incites primaquine toxicity through single-electron oxidation and modification.
Balaji SN; Trivedi V
J Basic Clin Physiol Pharmacol; 2013; 24(2):105-14. PubMed ID: 23412873
[TBL] [Abstract][Full Text] [Related]
20. IN VIVO GENERATION OF H2O2 IN MOUSE ERYTHROCYTES BY HEMOLYTIC AGENTS.
COHEN G; HOCHSTEIN P
J Pharmacol Exp Ther; 1965 Jan; 147():139-43. PubMed ID: 14255158
[No Abstract] [Full Text] [Related]
[Next] [New Search]
